Table 3.
Factors influencing the endoscopic retrograde cholangiopancreatography procedural time
|
Univariate analysis |
Multivariate analysis |
||||||
| Procedural time ≥ 70 min, n (yes/no) | OR | 95%CI | P value | OR | 95%CI | P value | |
| Age ≥ 76 yr | 13/9 | 2.09 | 0.63–6.94 | 0.23 | |||
| Sex, male | 17/20 | 0.34 | 0.06–1.98 | 0.23 | |||
| Period after B-II reconstruction ≥ 40 | 11/11 | 1.0 | 0.31–3.26 | 1.0 | |||
| Untreated papilla of Vater | 21/21 | 1.0 | 0.06–17.1 | 1.0 | |||
| Antithrombotic drug use | 3/4 | 0.71 | 0.14–3.63 | 0.68 | |||
| Periampullary diverticulum | 1/3 | 0.30 | 0.03–3.15 | 0.32 | |||
| Bile duct stone | 15/16 | 0.8 | 0.22–2.94 | 0.74 | |||
| Transverse diameter of largest stone ≥ 12.2 mm | 7/8 | 0.77 | 0.18–3.21 | 0.72 | |||
| Number of stones ≥ 2 | 10/7 | 2.29 | 0.52–10.0 | 0.27 | |||
| CS group | 17/10 | 4.08 | 1.11–5.0 | 0.035 | 3.97 | 1.05–15.0 | 0.04 |
| EST | 14/12 | 1.46 | 0.44–4.88 | 0.54 | |||
| EPBD or EPLBD | 10/9 | 1.20 | 0.37–3.97 | 0.76 | |||
| Papilla of Vater access | 20/19 | 1.58 | 0.24–10.5 | 0.64 | |||
| Stone clearance | 8/8 | 1.0 | 0.24–4.2 | 1.0 | |||
| Stone destruction | 6/3 | 2.67 | 0.52–13.7 | 0.24 | |||
| Procedural success | 15/19 | 0.34 | 0.07–1.54 | 0.16 | 0.36 | 0.07–1.74 | 0.2 |
EST: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilation; EPLBD: Endoscopic papillary large balloon dilation; CS: Colonoscopy; B-II: Billroth II.